Woebot Health vs Tempus AI
A detailed comparison to help you choose between Woebot Health and Tempus AI.
🏆
Verdict: Tempus AI wins
Tempus AI scores 4.1/5, edging out Woebot Health at 2.5/5. Cancer centers, molecular labs and health systems building precision-oncology programs that need sequencing, interpretation and data products under one roof — and pharma partners buying real-world data access.
Woebot Health AI mental health chatbot for CBT | Tempus AI AI for precision medicine and clinical genomics | |
|---|---|---|
| Rating | 2.5 (1 review) | 4.1 (1 review) |
| Pricing Model | freemium | paid |
| Starting Price | Free tier available | From $1000/mo |
| Best For | Health plans, provider organisations and researchers with a covered population to serve who want conversational CBT with published clinical evidence and can negotiate an enterprise contract. | Cancer centers, molecular labs and health systems building precision-oncology programs that need sequencing, interpretation and data products under one roof — and pharma partners buying real-world data access. |
| Free Tier | ||
| API Access | ||
| Team Features | ||
| Open Source | ||
| Tags | free tiermobile app | ssoteam features |
| Visit Woebot Health → | Visit Tempus AI → |
Woebot Health
Pros
- + Peer-reviewed randomised evidence behind the CBT dialogue — the 2017 JMIR RCT is one of the few in this category I consider methodologically serious
- + Between-session CBT exercises were genuinely fast in my use: a full thought record in roughly four minutes through chat
- + Crisis language screening with routing to external resources is built into the conversation layer, not bolted on
- + WB001 postpartum depression program holds FDA Breakthrough Device Designation (granted May 2021) with a double-blind pivotal trial underway since January 2023
- + Shutdown handling was disciplined: stated transcript deadline (July 15, 2025) and explicit data retention posture
Cons
- - The consumer app was retired June 30, 2025 — no new accounts, no individual purchase route at all
- - Pricing is quote-only per member per month or population licence; no published numbers to budget against
- - Scripted dialogue loops back to its CBT framework when conversations go off-script, in my experience within two exchanges
- - No FDA marketing authorisation for WB001; the company concluded in 2025 that pursuing it was not achievable at acceptable cost
- - Not a treatment for severe conditions — adjunctive support for mild to moderate presentations only
Tempus AI
Pros
- + FY2025 revenue of $1.3B with 126% net revenue retention and >$1.1B remaining contract value — verifiable public-company financials, not marketing claims
- + Complete assay portfolio in one relationship: xT/xR comprehensive profiling, xF+ liquid biopsy, MRD monitoring, Ambry hereditary testing and OneOme pharmacogenomics (national launch July 2026)
- + Tempus One answered voice queries against the patient's own clinical and molecular profile in my testing, with report citations instead of generic text
- + Paige Predict extends the platform into digital pathology — 123 biomarkers predicted from standard H&E slides across 16 cancer types (vendor-published validation)
- + Trial matching is built into the report workflow, which is the practical bottleneck for oncology coordinators
Cons
- - No self-serve access, no trial, and no published pricing of any kind — the $1,000 entry figure floating around listings could not be verified
- - Oncology-first scope; primary care and non-oncology specialties have little reason to engage
- - Still net-loss-making (-$245.0M in 2025), and the portfolio is stitched from four recent acquisitions (Ambry, Paige, OneOme, Deep 6)
- - Model-performance and data-library claims are company-published; independent third-party validation is thinner than the press-release volume suggests
- - Enterprise sales motion means long procurement cycles for health systems
Frequently Asked Questions
Which is better, Woebot Health or Tempus AI?▼
Tempus AI scores higher at 4.1/5 vs 2.5/5 for Woebot Health, making it the better-rated option in our comparison.
What is the difference between Woebot Health and Tempus AI?▼
Woebot Health: AI mental health chatbot delivering Cognitive Behavioral Therapy techniques and emotional support through conversational AI. Tempus AI: Tempus AI runs clinical and genomic sequencing and builds the diagnostics and data products used in precision oncology and other specialties.
Is Woebot Health or Tempus AI more affordable?▼
Woebot Health starts at €0/mo, Tempus AI starts at €1000/mo. Check the comparison table above for current pricing.
Stay in the loop
Get weekly updates on the best new AI tools, deals, and comparisons.
No spam. Unsubscribe anytime.